Topical imiquimod in the treatment of metastatic melanoma to skin

Archives of Dermatology

Volumn 139, Issue 3, 2003, Pages 273-276

  Wolf, Ingrid H ^a   Smolle, Josef ^a   Binder, Barbara ^a   Cerroni, Lorenzo ^a   Richtig, Erika ^a   Kerl, Helmut ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CARBOPLATIN; DACARBAZINE; FOTEMUSTINE; IMIQUIMOD;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CARBON DIOXIDE LASER; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTHERMIA; MALE; MELANOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SKIN METASTASIS; SPLIT THICKNESS SKIN GRAFT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; HUMANS; INTERFERON ALFA-2B; KNEE; LEG; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NITROSOUREA COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; SCALP; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0037342360     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.3.273     Document Type: Article

References (13)

1. Wigbels B, Luger T, Metze O. Imiquimod: eine neue Therapiemöglichkeit der bowenoiden Papulose? Hautarzt. 2001;52:128-131.
2. Steinmann A, Funk JO, Schuler G, von den Oriesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermtol. 2000; 43:555-556.
3. Hengge UR, Esser S, Schultewolter T, et al. Self-administrated topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol. 2000;143:1026-1031.
4. Gilbert J, Drehs MM, Weinberg JM. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection. Arch Dermatol. 2001;137:1015-1017.
5. Stockfleth E, Roewert J, Arndt R, Christophers E, Meyer T. Detection of human papillomavirus and response to topical 5% imiquimod in a case of stucco keratosis. Br J Dermatol. 2000;143:846-850.
6. Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999;41:1002-1007.
7. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol. 2001;44:807-813.
8. Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg. 2001;27:561-564.
9. Pehoushek J, Smith KJ. Imiquimod and 5% and 5% fluorouraciltherapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man. Arch Dermatol. 2001;137:14-16.
10. Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol. 2001;144:1050-1053.
11. Hengge UR, Stark R. Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol. 2001;137:709-711.
12. Oster-Schmidt C. Imiquimod: a new possibility for treatment-resistant verrucae planae. Arch Dermatol. 2001;137:666-667.
13. Schaen L, Mercurio MG. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream. Pediatr Dermatol. 2001;18:450-452.